Jon Wigginton
President/Vice-President/Immediate Past-President at International Society for Biological Therapy of Cancer (now Society for Immunotherapy of Cancer) | Washington DC-Baltimore Area, United States
Jon Wigginton’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Founder and President at Bethesda Biomedical Consulting, Inc. in April 2020 - Present
Member, Board Of Directors at Sutro Biopharma, Inc. in December 2020 - Present
President, Research and Development at Bright Peak Therapeutics in August 2022 - Present
Chairman SAB and Senior Advisor at Cullinan Oncology in May 2021 - August 2022
Member, Board of Directors at Checkmate Pharmaceuticals in January 2022 - May 2022
Portfolio Chief Medical Officer at Cullinan Oncology in April 2020 - May 2021
Chief Medical Officer and Senior Vice-President, Clinical Development at MacroGenics, Inc. in August 2013 - March 2020
Therapeutic Area Head, Early Clinical Development, Immuno-Oncology at Bristol-Myers Squibb in September 2010 - August 2013
Executive Medical Director, Discovery Medicine-Clinical Oncology at Bristol-Myers Squibb in October 2009 - August 2013
President/Vice-President/Immediate Past-President at Society for Immunotherapy of Cancer (SITC) in January 2004 - January 2010
Group Medical Director. Discovery Medicine-Clinical Oncology at Bristol-Myers Squibb in October 2008 - October 2009
Director, Clinical Oncology at Merck in May 2006 - October 2008
Head, Investigational Biologics Section at National Cancer Institute (NCI) in July 1992 - May 2007
Translational Immunologist | Biomarker & R&D Strategy Lead | Advancing Immuno-Oncology Innovation
- Biomarker Strategy Lead for Bright Peak's first-in-class αPD1-IL18 immunocytokine oncology clinical trial, BPT567-101 (NCT06779851, Phase IA/B)
- Translational Biology and PD Biomarker Expert driving discovery and development across Bright Peak's non-clinical portfolio
- Im...
CEO, Bright Peak Therapeutics
Bright Peak is a privately held biotechnology company based in Basel, Switzerland and San Diego, CA. We use our unique ability to chemically synthesize and conjugate proteins to create a portfolio of novel designer immunotherapies for the treatment of cancer and autoimmune dis...
Head of Biology, Senior Director
Head of Biology, Senior Director at Bright Peak Therapeutics
(Feb 2025 – Present)
SVP, Chemistry, Manufacturing and Controls at Bright Peak Therapeutics
VP, CMC at Bright Peak Therapeutics
(Nov 2021 – Present)
Co-founder & CTO, Bright Peak Therapeutics
Co-founder, CTO at Bright Peak Therapeutics
(Dec 2017 – Present)
Senior Scientist | Protein Engineering, Bioconjugation and Biophysical Characterization
Senior Scientist at Bright Peak Therapeutics
(Jan 2023 – Present)
What is Jon Wigginton email address?
Email Jon Wigginton at [email protected] and [email protected]. This email is the most updated Jon Wigginton's email found in 2026.
How to contact Jon Wigginton?
To contact Jon Wigginton send an email to [email protected] or [email protected].
What industry does Jon Wigginton work in?
Jon Wigginton works in the Pharmaceuticals industry.
